The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?
暂无分享,去创建一个
[1] P S Schenck,et al. CONTROL OF COMMUNICABLE DISEASES. , 1914, American journal of public health.
[2] S. Miller,et al. Control of communicable diseases. , 1949, The Journal-lancet.
[3] I. L. Bennett,et al. Brucellosis. I. Laboratory-acquired acute infection. , 1959, A.M.A. archives of internal medicine.
[4] H. Wilson,et al. Tularemia vaccine study. II. Respiratory challenge. , 1961, Archives of internal medicine.
[5] F. McCrumb,et al. AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS. , 1961, Bacteriological reviews.
[6] A. Hogge,et al. Antibiotic prophylaxis and therapy of airborne tularemia. , 1966, Bacteriological reviews.
[7] Perspective , 1974 .
[8] D. Commerce. Statistical abstract of the United States , 1978 .
[9] A. Kaufmann,et al. AIRBORNE SPREAD OF BRUCELLOSIS , 1980, Annals of the New York Academy of Sciences.
[10] J. Canela-Soler,et al. An outbreak of Brucella melitensis infection by airborne transmission among laboratory workers. , 1987, American journal of public health.
[11] A. Hallam. The competitive firm's response to risk , 1987 .
[12] M. Zervos,et al. Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital. , 1989, Journal of clinical microbiology.
[13] D H Walker,et al. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Ezzell,et al. Postexposure prophylaxis against experimental inhalation anthrax. , 1993, The Journal of infectious diseases.
[15] J. Feldman,et al. Health, United States, 1993 , 1994 .
[16] M. Hugh-jones,et al. The Sverdlovsk anthrax outbreak of 1979. , 1994, Science.
[17] J. Solera,et al. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas , 1995, Antimicrobial agents and chemotherapy.
[18] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[19] L. Cole,et al. The specter of biological weapons. , 1996, Scientific American.
[20] C. Roelofs. Prevention effectiveness: A guide to decision analysis and economic evaluation , 1997 .
[21] Shane Marley,et al. Control of Communicable Diseases Manual , 1997, Annals of Internal Medicine.